Biotage AB (publ) – board member Anders Walldov leaves his assignments
Anders Walldov, member of the Board of Directors, sold his and with him related companies’ entire shareholding in Biotage on 17 May 2016.
Anders Walldov will keep his assignments as a Board Member and a member of the Compensation Committee up and until the Board meeting on 10 August 2016. A new member of the Compensation Committee will be appointed at the forthcoming Board meeting.
The current Nomination Committee has not notified the company about any intention to suggest a new member of the Board of Directors in advance of convening the new Nomination Committee for the 2017 AGM.
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 9 am CET on 1 June 2016.
Torben Jörgensen, CEO
Tel: 0707-49 05 84, firstname.lastname@example.org
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 610 MSEK in 2015. Biotage is listed on the NASDAQ OMX Stockholm stock exchange. Website: www.biotage.com